Citations (14)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Korakrit Imwattana, Daniel R Knight & Thomas V Riley. (2021) Can sequencing improve the diagnosis and management of Clostridioides difficile infection?. Expert Review of Molecular Diagnostics 21:5, pages 429-431.
Read now
Read now
Articles from other publishers (13)
Lei Wang, Meng Diao, Zheng Zhang, Minlin Jiang, Shifu Chen, Deping Zhao, Zhenguo Liu & Caicun Zhou. (2024) Comparison of the somatic genomic landscape between central- and peripheral-type non-small cell lung cancer. Lung Cancer 187, pages 107439.
Crossref
Crossref
Wanying Jia, Haiyan Yu, Li Song, Jian Wang, Shuyu Niu, Guojie Zang, Mingjie Liang, Jinwei Liu & Risu Na. (2023) Development of clinical trials for non-small cell lung cancer drugs in China from 2005 to 2023. Frontiers in Medicine 10.
Crossref
Crossref
Huiyun Lv, Aijuan Tian, Shanshan Zhao, Jinbo Zhao & Chen Song. (2023) Next-generation sequencing-based detection in a breast MMPMN patient with EGFR T790M mutation: a rare case report and literature review. Frontiers in Oncology 13.
Crossref
Crossref
Yanqing Liu, Qiong Liu, Zhe Zhang, Yaru Yang, Yazhe Zhou, Huanle Yan, Xin Wang, Xiaoru Li, Jing Zhao, Jingyan Hu, Shulin Yang, Yifan Tian, Yu Yao, Zhenye Qiu, Yanbin Song & Yang Yang. (2023) The regulatory role of PI3K in ageing-related diseases. Ageing Research Reviews 88, pages 101963.
Crossref
Crossref
Fangfang Shen, Wei Guo, Xia Song & Bei Wang. (2023) Molecular profiling and prognostic biomarkers in chinese non-small cell lung cancer cohort. Diagnostic Pathology 18:1.
Crossref
Crossref
Yu Pang, Daosheng Li, Yiqian Chen, Qinqin Liu, Yuheng Wu, Qingliang Teng & Yuyu Liu. (2023) Thymus and lung mucosa-associated lymphoid tissue lymphoma with adenocarcinoma of the lung: a case report and literature review. World Journal of Surgical Oncology 21:1.
Crossref
Crossref
Jing Fu, Yuyang Tong, Ziguang Xu, Yaonan Li, Ya Zhao, Tao Wang, Cuidan Li & Shundong Cang. (2023) Impact of TP53 Mutations on EGFR-Tyrosine Kinase Inhibitor Efficacy and Potential Treatment Strategy. Clinical Lung Cancer 24:1, pages 29-39.
Crossref
Crossref
Fei Xu, Wen‐qiang Cui, Cun Liu, Fubin Feng, Ruijuan Liu, Jingtao Zhang & Chang‐gang Sun. (2022) Prognostic biomarkers correlated with immune infiltration in non‐small cell lung cancer. FEBS Open Bio 13:1, pages 72-88.
Crossref
Crossref
Xuli Yang, Tao Chen, Jie Hu, Jian Wang & Dong Yang. (2022) HKI-272 contributes to gemcitabine-mediated anti-proliferative and anti-metastatic effects through EGFR suppression in gallbladder cancer. Molecular Therapy - Oncolytics 27, pages 126-140.
Crossref
Crossref
Zhiwei Liu, Ruibing Su, Anil Ahsan, Chencai Liu, Xiaoqi Liao, Dongping Tian & Min Su. (2022) Esophageal Squamous Cancer from 4NQO-Induced Mice Model: CNV Alterations. International Journal of Molecular Sciences 23:22, pages 14304.
Crossref
Crossref
Fei Wang, Chong Yuan, Bo Liu, Yan-Fang Yang & He-Zhen Wu. (2022) Syringin exerts anti-breast cancer effects through PI3K-AKT and EGFR-RAS-RAF pathways. Journal of Translational Medicine 20:1.
Crossref
Crossref
Lamei Huang, Zhixing Guo, Fang Wang & Liwu Fu. (2021) KRAS mutation: from undruggable to druggable in cancer. Signal Transduction and Targeted Therapy 6:1.
Crossref
Crossref
Ting-Ting Liu, Rui Li, Chen Huo, Jian-Ping Li, Jie Yao, Xiu-li Ji & Yi-Qing Qu. (2021) Identification of CDK2-Related Immune Forecast Model and ceRNA in Lung Adenocarcinoma, a Pan-Cancer Analysis. Frontiers in Cell and Developmental Biology 9.
Crossref
Crossref